Markers for premature birth risk at the molecular level

NewsGuard 100/100 Score

For the first time, researchers have successfully profiled the amniotic fluid metabolome (the sum of all metabolic processes occurring in the amniotic fluid), in order to identify which women who have experienced preterm labor are also at risk for delivering a premature baby.

With nearly one in eight babies in the U.S. born prematurely every year, and the problem of premature birth increasing, the need for tools that can identify preterm delivery risk has never been greater, experts say.

The news was announced today at the 25th annual Society for Maternal-Fetal Medicine (SMFM).

"We studied the amniotic fluid of three groups of patients – those with preterm labor who delivered at term, those with intra-amniotic inflammation who had both preterm labor and delivery, and those with no sign of inflammation who still had preterm labor and delivery," said Roberto Romero, M.D., lead study author and SMFM member. "We discovered that by using metabolic profiling, 96 percent of the time we could correctly identify the patients as belonging to the appropriate clinical group.

"A second study, in a different set of patients with a larger sample size, has already confirmed the effectiveness of our method. Until now, we have never had a way to predict the course of preterm labor with such accuracy. Metabolomic profiling has given us that tool," Dr. Romero said.

"Prematurity is a common, serious, and growing problem in this country," said Nancy S. Green, M.D., medical director of the March of Dimes. "More research to identify and address the risk factors for prematurity are needed if we are to reverse this trend. The innovative nature of this study has earned it our annual award for the best research paper on prematurity."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses